Standard Biotools Inc. (LAB) — 10-Q Filings
All 10-Q filings from Standard Biotools Inc.. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
-
Standard BioTools' Q3 Loss Widens Amid Revenue Dip, Soaring Restructuring Costs
— Nov 4, 2025 Risk: high
STANDARD BIOTOOLS INC. (LAB) reported a net loss of $34.687 million for the three months ended September 30, 2025, an increase from a net loss of $26.938 millio -
Standard BioTools Files 10-Q for Q2 2025
— Aug 15, 2025 Risk: medium
Standard BioTools Inc. filed its 10-Q for the period ending June 30, 2025. The company, formerly Fluidigm Corp, is involved in laboratory analytical instruments -
Standard BioTools Files Q1 2025 10-Q
— May 6, 2025 Risk: medium
Standard BioTools Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly Fluidigm Corp, is based in South San Francisco, CA. Key financ -
Standard BioTools Files Q3 2024 10-Q
— Nov 6, 2024 Risk: medium
Standard BioTools Inc. filed its 10-Q for the period ending September 30, 2024. The company, formerly Fluidigm Corp, is involved in laboratory analytical instru -
Standard BioTools Files Q2 2024 10-Q
— Aug 6, 2024 Risk: medium
Standard BioTools Inc. filed its 10-Q for the period ending June 30, 2024. The company, formerly Fluidigm Corp, reported on its financial performance and busine -
STANDARD BIOTOOLS INC. Files 10-Q for Period Ending March 31, 2024
— May 9, 2024 Risk: medium
STANDARD BIOTOOLS INC. (LAB) filed a Quarterly Report (10-Q) with the SEC on May 9, 2024. STANDARD BIOTOOLS INC. filed a 10-Q for the period ending March 31, 20
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX